- The trend backdrop is active with a 8-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Activity pressure is constructive, supporting the smart-money activity read.
IMMU
STO
Week ended 07 Aug 2026
Weekly Investor Report
Mendus AB (publ) · Healthcare · Biotechnology
Latest close
6.85 SEK
-1.3%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 25.8% above the Trend Line and sits at 48.5% of its 52-week range. The latest completed week returned -1.3%, after a 0.4% four-week move. The latest news-sentiment score is 57/100. Near-term considerations: volume confirmation is below normal.
Setup score
42
out of 100
Latest Close
6.85 SEK
7 Aug 2026
1W Return
-1.3%
latest completed week
4W Return
0.4%
short-term follow-through
12W Return
16.1%
quarterly tape
Trend Breadth
30.8%
16 of 52 weeks active
Volume Ratio
0.6x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 36.11% based on similar historical setup states.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.3%
Latest completed week; four-week move 0.4%.
Indicator stack
45/66
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 36.11%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
57/100
2 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 25.8% above the Trend Line and sits at 48.5% of its 52-week range. The latest completed week returned -1.3%, after a 0.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.6712-week average 0.38
12-week confirmation
Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.67Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 0.4% over four weeks, 16.1% over 12 weeks, and -13.9% over one year. The current trend has remained active for 8 consecutive weeks.
Performance by holding period
Active trend streak8 weeks
Active weeks in one year16
Trend breadth30.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.99Latest activity-pressure read.
Pressure change-18.8%Four-week change in activity pressure.
Leadership4.32Latest relative-leadership reading.
RS change34.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment57/100
Weighted news tone is neutral across 2 relevant articles.
1 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-31.6%Distance below the 52-week high.
13-week volatility9.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2613 weeks finished lower.
Best week+23.5%Week of 19 Jun.
Worst week-12.0%Week of 17 Jul.
Latest week-1.3%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains4
Flat weeks1
Modest losses8
Sharp losses5
Recent vol9.7%13-week weekly-return volatility.
Base vol8.6%52-week weekly-return volatility.
Up/down split19/30Count of positive and negative weeks in the 52-week window.
Average skew8.8% / -5.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSE Healthcare
4-week rank43 / 100
Group average-1.1%
Trend breadth39.0%
Trend39.0%active weekly trend signals
MD42.0%positive activity pressure
RS21.0%positive relative leadership
Four-week leaders
IndustrySE Biotechnology
4-week rank20 / 58
Group average3.5%
Trend breadth39.7%
Trend39.7%active weekly trend signals
MD53.4%positive activity pressure
RS22.4%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape41/100
Trend, activity pressure, participation, and risk combine to a 41/100 tape read.
Indicator analysis65/100Latest 12-week confirmation: trend 8/12, activity pressure 12/12, relative leadership 4/12.
Activity pressure 0.67; No reversal markers Next-Week ExpectancyNegative 36.11%Next-week expectancy is negative with a 36.11% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment57/100Weighted news tone is neutral across 2 relevant articles.
Mendus board member Sijmen de Vries makes a small share purchase Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 6.85 SEK | -1.3% | 5.44 SEK | 7.53 SEK | 0.99 | 4.32 | 69.9K | On |
| 31 Jul 2026 | 6.94 SEK | 6.6% | 5.41 SEK | 7.54 SEK | 1.13 | 6.80 | 92.3K | On |
| 24 Jul 2026 | 6.51 SEK | 8.5% | 5.37 SEK | 7.55 SEK | 1.09 | 0.12 | 75.4K | On |
| 17 Jul 2026 | 6.00 SEK | -12.0% | 5.33 SEK | 7.57 SEK | 1.10 | -7.33 | 101.8K | On |
| 10 Jul 2026 | 6.82 SEK | 11.6% | 5.32 SEK | 7.59 SEK | 1.21 | 3.22 | 273.9K | On |
| 3 Jul 2026 | 6.11 SEK | -1.5% | 5.25 SEK | 7.61 SEK | 0.97 | -10.12 | 32.1K | On |
| 26 Jun 2026 | 6.20 SEK | -1.6% | 5.22 SEK | 7.63 SEK | 0.86 | -7.35 | 29.4K | On |
| 19 Jun 2026 | 6.30 SEK | 23.5% | 5.18 SEK | 7.66 SEK | 0.87 | -7.47 | 241.5K | On |
| 12 Jun 2026 | 5.10 SEK | 0.6% | 5.15 SEK | 7.68 SEK | 0.84 | -24.07 | 5.4K | Off |
| 5 Jun 2026 | 5.07 SEK | -10.9% | 5.17 SEK | 7.71 SEK | 1.07 | -25.23 | 5.1K | Off |
| 29 May 2026 | 5.69 SEK | 0.0% | 5.22 SEK | 7.77 SEK | 1.20 | -17.02 | 113.4K | Off |
| 22 May 2026 | 5.69 SEK | -3.6% | 5.28 SEK | 7.90 SEK | 1.05 | -17.45 | 147.8K | Off |
| 15 May 2026 | 5.90 SEK | 14.8% | 5.29 SEK | 8.00 SEK | 0.75 | -11.52 | 443.2K | Off |
| 8 May 2026 | 5.14 SEK | 0.2% | 5.29 SEK | 8.12 SEK | 0.43 | -23.98 | 177.5K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.